Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
50 participants
INTERVENTIONAL
2009-01-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices
NCT06403644
The Impact of Biophoton Therapy on Self-Grown Stem Cells
NCT06855459
How Does Continued Use of Green Light Therapy Impact Outcomes?
NCT07282275
Neuro RX Gamma - Pivotal Phase
NCT03484143
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
NCT05016219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Telomeres will be measured at the end of each year for 5 years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telomere length, GigaHz exposure
Measurement of white blood cell telomeres before and yearly for 5 years
Exposure to GHz electromagnetic energy (RejuvaMatrix)
75 decibels of 54 to 78 GHz daily for 60 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure to GHz electromagnetic energy (RejuvaMatrix)
75 decibels of 54 to 78 GHz daily for 60 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Major, debilitating disease
* Person living with an individual who has an implanted device
* Person who is or could become pregnant
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Holos Institutes of Health, Inc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
C. Norman Shealy
M.D., Ph.D.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HIH RM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.